US Patent Issued to TRx Biosciences on July 14 for "Compositions having improved bioavailability of therapeutics" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,502, issued on July 14, was assigned to TRx Biosciences Ltd. (London). "Compositions having improved bioavailability of therapeutics" was i... Read More

US Patent Issued to The Brigham and Women's Hospital on July 14 for "Water-activated mucoadhesive compositions and methods of delivering biologically active substances" (Massachusetts Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,503, issued on July 14, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Water-activated mucoadhesive compositions and meth... Read More

US Patent Issued to Noven Pharmaceuticals on July 14 for "Stable transdermal amphetamine compositions and methods of manufacture" (Florida Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,504, issued on July 14, was assigned to Noven Pharmaceuticals Inc. (Miami). "Stable transdermal amphetamine compositions and methods of man... Read More

US Patent Issued to ANTECIP BIOVENTURES II on July 14 for "Pharmaceutical compositions comprising bupropion and cysteine" (New York Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,506, issued on July 14, was assigned to ANTECIP BIOVENTURES II LLC (New York). "Pharmaceutical compositions comprising bupropion and cystei... Read More

US Patent Issued to Icahn School of Medicine at Mount Sinai on July 14 for "Protein tyrosine kinase 6 (PTK6) degradation / disruption compounds and methods of use" (New York Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,507, issued on July 14, was assigned to Icahn School of Medicine at Mount Sinai (New York). "Protein tyrosine kinase 6 (PTK6) degradation /... Read More

US Patent Issued to DANA-FARBER CANCER INSTITUTE on July 14 for "Compounds for targeted degradation of interleukin-2-inducible T-cell kinase and methods of use" (Massachusetts, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,508, issued on July 14, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "Compounds for targeted degradation of interleukin-2-in... Read More

US Patent Issued to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on July 14 for "Inhibitor of apoptosis (IAP) protein antagonists" (American, German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,509, issued on July 14, was assigned to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, Calif.). "Inhibitor of apoptosis (IAP... Read More

US Patent Issued to Northwestern University on July 14 for "Drug loaded peptide brush polymers" (Illinois Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,510, issued on July 14, was assigned to Northwestern University (Evanston, Ill.). "Drug loaded peptide brush polymers" was invented by Nath... Read More

US Patent Issued to DAIICHI SANKYO on July 14 for "Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide derivative" (Japanese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,512, issued on July 14, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo). "Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide ... Read More

US Patent Issued to BOLT BIOTHERAPEUTICS on July 14 for "Anti-HER2 immunoconjugates, and uses thereof" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,513, issued on July 14, was assigned to BOLT BIOTHERAPEUTICS INC. (Redwood City, Calif.). "Anti-HER2 immunoconjugates, and uses thereof" wa... Read More

• ««
• «
• 174466
• 174467
• 174468
• 174469
• 174470
• 174471
• 174472
• 174473
• 174474
• 174475
• »
• »»